| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0de3c2a3b6a654048399cc756869a0f3 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067 |
| filingDate |
2008-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbffc99b5dfe4cb227f1cd64780738b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b03dbd34ce57244ca7de79b48219aadf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4e8221b01f0e0564cab5e0036133a0a |
| publicationDate |
2010-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2391956-C1 |
| titleOfInvention |
Method of lacrimal ductus blocking in patients with dry eye syndrom |
| abstract |
FIELD: medicine. n SUBSTANCE: invention belongs to medicine, notably to ophthalmology. In lacrimal ductus, at 1-2 mm depth must be instilled 0.1-0.2 ml of the chlorine e6 covalently bound conjugate with human albumin in the molar ratio 1:2.5. Zone of instillation must be exposed to laser light with optical flux 500 mW during 1-2 minutes. Light's wavelength must comply with maximum absorption of optical emission by chlorin e6. n EFFECT: method allows to block lacrimal passages effectively and atraumatically up to necessary capacity. n 1 tbl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2463022-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2712394-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-220287-U1 |
| priorityDate |
2008-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |